51 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
in the Company’s business environment, a significant organizational change, research or clinical milestones, significant merger and acquisition … ”).
The possible ramifications of the Ratio on the daily working environment in Notable were examined and will continue to be examined by Notable from
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
changes, significant changes in the Company’s business environment, a significant organizational change, research or clinical milestones, significant … in the Companies Law) (the “Ratio”).
The possible ramifications of the Ratio on the daily working environment in Notable were examined and will continue
8-K/A
EX-99.2
NTBL
Notable Labs Ltd
29 Nov 23
Financial Statements and Exhibits
5:00pm
will generate revenue from product sales. The Company operates in an environment of rapid technological change and substantial competition from other … , over a similar term, an amount equal to the lease payments in a similar economic environment. Applying different judgments to the same facts
424B3
ggkdr ownb14
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
muytbgv75a8xr
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4/A
EX-10.20
jpqemdl7m fvdw
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
S-4
xi7bzqvq
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.11
ej8 c728px5vjl6k
11 May 23
Registration of securities issued in business combination transactions
9:09am
6-K
EX-1.1
7rf wehycsylw13ofk
11 Feb 22
Current report (foreign)
5:29pm
424B5
gibzjbx5g7
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.3
lybgqjebx
15 Nov 21
VBL Therapeutics Reports Third Quarter 2021 Financial Results
7:00am
POS AM
huzpuaqt9 vtowc18m
19 Apr 21
Prospectus update (post-effective amendment)
5:17pm
424B8
p4js0uqwo1qqi0b9me
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
pksmgnra
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am